Haemonetics Corporation (HAE)

Haemonetics Market Cap

Haemonetics has a market cap or net worth of $4.62 billion as of April 26, 2024. Its market cap has increased by 9.01% in one year.

• Market Cap: 4.62B
• Enterprise Value: 5.30B
• 1-Year Change: 9.01%
• Ranking: #1281
• Category: Mid-Cap
• Stock Price: $90.99

Market Cap Chart

Since December 1, 1998, Haemonetics's market cap has increased from $605.00M to $4.62B, an increase of 663.81%. That is a compound annual growth rate of 8.33%.

Market Cap History

Date	Market Cap	% Change
Apr 26, 2024	4.62B	3.80%
Apr 25, 2024	4.45B	1.67%
Apr 24, 2024	4.38B	1.35%
Apr 23, 2024	4.32B	1.74%
Apr 22, 2024	4.25B	2.93%
Apr 19, 2024	4.13B	-2.66%
Apr 18, 2024	4.24B	-1.67%
Apr 17, 2024	4.31B	0.84%
Apr 16, 2024	4.27B	-0.84%
Apr 15, 2024	4.31B	-0.40%
Apr 12, 2024	4.33B	-1.50%
Apr 11, 2024	4.39B	0.43%
Apr 10, 2024	4.38B	-1.04%
Apr 9, 2024	4.42B	2.04%
Apr 8, 2024	4.33B	0.79%
Apr 5, 2024	4.30B	-0.28%
Apr 4, 2024	4.31B	1.15%
Apr 3, 2024	4.26B	-0.30%
Apr 2, 2024	4.27B	-0.73%
Apr 1, 2024	4.31B	-0.66%
Mar 28, 2024	4.33B	1.50%
Mar 27, 2024	4.27B	3.00%
Mar 26, 2024	4.15B	-0.22%
Mar 25, 2024	4.16B	1.92%
Mar 22, 2024	4.08B	-0.01%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Halozyme Therapeutics	4.89B
Organon & Co.	4.71B
CRISPR Therapeutics AG	4.56B
BridgeBio Pharma	4.49B
Lantheus Holdings	4.47B
Krystal Biotech	4.40B
Doximity	4.40B
Merit Medical Systems	4.25B